Dial­y­sis provider Fre­se­nius Med­i­cal Care didn’t cause the death of a pa­tient at a clinic, a Mas­sachusetts jury found last week.

Modern Healthcare - - LATE NEWS -

The de­ci­sion came one year after Fre­se­nius agreed to pay $250 mil­lion to set­tle thou­sands of law­suits from dial­y­sis pa­tients and their fam­i­lies claim­ing the com­pany’s treat­ments caused car­diac ar­rest and some­times death. The Mas­sachusetts case is the first bell­wether trial over the is­sue. Fre­se­nius ini­tially came un­der fire in 2012 for its GranuFlo treat­ment after the com­pany sent a memo to its doc­tors warn­ing the prod­uct was con­tribut­ing to an in­crease of pa­tients dy­ing from car­diac ar­rest. The Food and Drug Ad­min­is­tra­tion launched an in­ves­ti­ga­tion shortly af­ter­ward. Fre­se­nius even­tu­ally re­called the prod­uct. More than 10,000 law­suits were filed, most of which were set­tled.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.